NORTH AMERICAN VACCINE (NVX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
NORTH AMERICAN VACCINE (NVX)

An SI Board Since February 1997

Posts	SubjectMarks	Bans	Symbol
21	0	0	NVX

Emcee: Don W Stone	Type: Unmoderated

Introduction Market Data Compact

MORE NEWS:
" North American Vaccine today announced that the US Patent Office has issued a patent covering chemically modified meningococcal B polysaccharides, and conjugate vaccines incorporating the modified polysaccharides."

Saron Mates, Ph.D, President of North American Vaccine said " This patent significantly enhances the value of the Company's technology and will play a key role in the commercialization of this important vaccine."

This is the sort of news that is driving the stock right now IMO.
NVX is now beginning to be recognized by the investment community as alot more than a one product(DTaP) company. It is my opinion that NVX's pipeline of some 15 different products has alot more value than NVX's present market cap. :-}

Visit their home page and click products. nava.com

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
21	"On Track for Completing Final Steps for Lincensure" Company spokesm	Don W Stone	-	1/12/1998
20	Hambreck & Quist Medical Conference Tuesday, California :-} NVX will be pr	Don W Stone	-	1/11/1998
19	Discard EMOTIONS, THINK POSITIVE Thank goodness this press release came out on	Don W Stone	-	1/11/1998
18	James Baker: This is ONE BIG STEP FORWARD. Although your reaction is not surpri	Don W Stone	-	1/10/1998
17	Somehow this does not sound all that positive. After all this time why should	James Baker	-	1/10/1998
16	This is surely not the time to run out of PATIENCE with NVX. We certainly are	Don W Stone	-	8/11/1997
15	Andy- I got into www.aol.com and put in investors network in NetFind and got no	kech	-	3/23/1997
14	Tom: You dont have access to AOL? If you do, just type in keywork Investors Ne	andy harrison	-	3/22/1997
13	Andy - Could you post them here or give a URL?	kech	-	3/21/1997
12	GOTO AOL's Investors Network (KEYWORD-INVESTORS NETWORK) and READ THE POSTI	andy harrison	-	3/13/1997
11	Missing the date of approval as you suggest has nothing to do with NVX but rath	andy harrison	-	3/8/1997
10	I agree that recent weakness was probably not caused by Goldman conf on vaccine	Tom Stone	-	3/6/1997
9	Supposedly Sharon Mates did her usual presentation. According to sources it wen	andy harrison	-	3/5/1997
8	Andy do you or Don know anything about a Goldman Sach conference on vaccines he	Tom Stone	-	2/28/1997
7	Short interest in NVX is up to 3,773,856 (ending 2/14/97) which is an 8% increa	andy harrison	-	2/23/1997
6	Don - I think your James Davidson is the same man that wrote the books "Bl	Tom Stone	-	2/21/1997
5	From Strategic Investment, feb 19, 1997 This particular piece was written by a	Don W Stone	-	2/21/1997
4	Don: The thrust of the Individual Investor article about NVX was that they woul	andy harrison	-	2/10/1997
3	Don: You forgot to include that the "unnamed bear" had the magazine p	andy harrison	-	2/8/1997
2	After reading what I have said in the prior post I do feel I missed the intende	Don W Stone	-	2/7/1997
1	To All:About Integrity in Journalism; In the March '97 issue of Individual	Don W Stone	-	2/6/1997

Go to reply# or date (mm/dd/yy):